#EULAR2022 ASAS-EULAR guidelines for axSpA with Dr. @sofiaramiro82. Below are the recommendations including b/tsDMARDs. If ASDAS > 2.1 the recommendations call for consideration for TNFi, IL17i, or JAKi. Re-evaluate after at least 12 weeks on tx and for co-morbidities. @RheumNow https://t.co/mryL3YmtzN